Clinical Trials Research Alliance (CTRA)

SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

About this Trial

An International Phase 3 Randomized, Double-blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Administered with and without Low-Dose Estradiol and Norethindrone Acetate in Women with Endometriosis

  • Status: Enrolling now
  • Location: Miami Valley Hospital
  • Study type: Interventional
  • Ages eligible for study: 18 to 50 years
  • Genders eligible for study: Female
  • Principal Investigator: Dr. Michael Galloway
  • For more information about this study, visit NCT03204331

Contact Us

If you would like information about participating in this study, contact:

Dawn Shields, BS
(937) 208-3689

Last edited on 01/11/2019.